DCT

1:20-cv-00580

Novo Nordisk Healthcare AG v. Laboratoire Francais Du Fractionnement Et des Biotech SA

General

Filed

04/28/20

Cause of ActionWillful Patent Infringement

SectorBiotech

StatusClosed

Patent Owner

Operating Company

PACER1:20-cv-00580

Nature of Suit830 Patent

CourtD. Delaware

Judge	Period	PO Win Rate
Leonard P. Stark	--	41%

Plaintiff

Party

Name	Ratings
Novo-Nordisk AS NPE	L2D
Novo Nordisk Inc	L2E

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Brian P. Egan	L4B
Fenwick & West LLP	L4A
Jeffrey J. Oelke	L5A
Kathryn Easterling	L2-- --
Catherine McCord	L1C

Defendant

Party

Name	Ratings
Laboratoire Francais du Fractionnement et Des Biotechnologies	---- --
Hema Biologics LLC	---- --

Attorney

Name	Ratings
Jones Day	L5A
Anthony Insogna	L5A
John J. Normile	L5A
Kelsey I. Nix	L5B
Jennifer L. Swize	L4D
Kevin V. McCarthy	L3E
Foley & Lardner LLP	L5B
Michael Houston	L4B
Tiffany Kim Sung	L3B
Jayita Guhaniyogi	L3D
Jason N. Mock	---- --
McCarter & English LLP	L4A
Daniel M. Silver	L5A
Alexandra M. Joyce	L3C
Gibson Dunn & Crutcher LLP	L4C
Jane M. Love	L4C
Ronald A. Lee	L4D
Polsinelli	L3E
Stephen J. Kraftschik	L5D
Attorney at LawLocal	---- --
George E. Quillin	---- --